Change the keyword or sentiment above, then click Apply.
Thursday, 17 Sep 20261 update
↔ AI sentiment: Neutral
59% confidence
Fischer Showcases AI Imaging in New Investor Deck
Fischer Medical Ventures released a revised investor presentation replacing Sept 7, 2026 version.
The presentation highlights AI-powered imaging, proprietary tech, and strong management expertise.
Source: ScoutQuest
Monday, 07 Sep 20261 update
↔ AI sentiment: Neutral
69% confidence
Fischer Medical Ventures: Expands Southeast Asian Healthcare With New 3T Imaging Development
Friday, 04 Sep 20261 update
↔ AI sentiment: Neutral
93% confidence
Fischer Medical Ventures: Plans Meeting With Analysts And Investors On September 7.
Thursday, 03 Sep 20261 update
↔ AI sentiment: Neutral
92% confidence
Fischer Medical Names David Yeow as Independent Director for 5-Year Term
Fischer Medical Ventures appointed David Yeow as an Independent Director for a 5-year term starting 3rd Sep 2026.
The Board reconstituted the Audit Committee and scheduled the 33rd AGM for 29th Sep 2026 via video conferencing.
Source: BSE
Friday, 28 Aug 20261 update
↔ AI sentiment: Neutral
73% confidence
Fischer Medical Ventures: Subsidiary Introduces Clarion 64/128-Slice AI-Powered CT System In India
Monday, 24 Aug 20261 update
↔ AI sentiment: Neutral
77% confidence
Fischer's Unit Wins Digital Health Project in Philippines
Fischer Medical Ventures' subsidiary, Time Medical Philippines, secured a digital healthcare project in Catanduanes Province.
The project combines Health Kiosks and FlynnCare CMS to support Universal Health Care digitalization in the Philippines.
Source: BSE